Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy

Autor:	E. van Sonnenberg, Sridhar Shankar, Adib R. Karam, Sathish Kumar Dundamadappa, R. M. Stay
Rok vydání:	2009
Předmět:	Pathology medicine.medical_specialty Stromal cell Gastrointestinal Stromal Tumors Contrast Media Antineoplastic Agents Piperazines Metastasis Predictive Value of Tests Outcome Assessment Health Care Humans Medicine Radiology Nuclear Medicine and imaging neoplasms Radiological and Ultrasound Technology medicine.diagnostic_test GiST business.industry Mesenchymal stem cell Cancer Magnetic resonance imaging Imatinib General Medicine medicine.disease Magnetic Resonance Imaging digestive system diseases Pyrimidines Imatinib mesylate Benzamides Disease Progression Imatinib Mesylate Neoplasm Recurrence Local Tomography X-Ray Computed business medicine.drug
Zdroj:	Acta Radiologica. 50:837-844
ISSN:	1600-0455 0284-1851
Popis:	Gastrointestinal stromal tumors (GISTs) account for the majority of gastrointestinal mesenchymal tumors. Recent advances in treatment using the molecular targeting agent imatinib mesylate have shown startling response rates and variegated imaging findings. We present the various imaging appearances of GIST on computed tomography (CT) and magnetic resonance imaging (MRI), both before and after treatment.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc1762b3edf50ee20df448ec88982dfd https://doi.org/10.1080/02841850903059423 Zobrazit plný text záznamu